BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29747813)

  • 1. Biology of GM3 Ganglioside.
    Inokuchi JI; Inamori KI; Kabayama K; Nagafuku M; Uemura S; Go S; Suzuki A; Ohno I; Kanoh H; Shishido F
    Prog Mol Biol Transl Sci; 2018; 156():151-195. PubMed ID: 29747813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homeostatic and pathogenic roles of the GM3 ganglioside.
    Inokuchi JI; Kanoh H; Inamori KI; Nagafuku M; Nitta T; Fukase K
    FEBS J; 2022 Sep; 289(17):5152-5165. PubMed ID: 34125497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The regulation of ganglioside GM3 synthesis].
    Uemura S
    Yakugaku Zasshi; 2012; 132(8):895-901. PubMed ID: 22864347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiopathological function of hematoside (GM3 ganglioside).
    Inokuchi J
    Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(4):179-98. PubMed ID: 21558756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganglioside GM3 deficiency enhances mast cell sensitivity.
    Komuro M; Mizugaki H; Nagane M; Morimoto M; Fukuyama T; Ogihara K; Naya Y; Yokomori E; Kaneshima K; Kawakami Y; Kamiie J; Shibata Y; Suzuki M; Shimizu T; Kawashima N; Okamoto M; Ikeda T; Yamashita T
    FEBS J; 2023 Sep; 290(17):4268-4280. PubMed ID: 37098812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient ganglioside synthesis restores responsiveness to leptin and melanocortin signaling in obese KKAy mice.
    Inamori KI; Ito H; Tamura Y; Nitta T; Yang X; Nihei W; Shishido F; Imazu S; Tsukita S; Yamada T; Katagiri H; Inokuchi JI
    J Lipid Res; 2018 Aug; 59(8):1472-1481. PubMed ID: 29880531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside GM3 Synthase Deficiency in Mouse Models and Human Patients.
    Inamori KI; Inokuchi JI
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3.
    Nagafuku M; Sato T; Sato S; Shimizu K; Taira T; Inokuchi J
    Glycobiology; 2015 Mar; 25(3):303-18. PubMed ID: 25303960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Homeostatic and Pathophysiological Regulation of Toll-like Receptor 4 Signaling by GM3 Ganglioside Molecular Species].
    Kanoh H
    Yakugaku Zasshi; 2022; 142(3):195-203. PubMed ID: 35228371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor hypoxia regulates ganglioside GM3 synthase, which contributes to oxidative stress resistance in malignant melanoma.
    Shimizu T; Nagane M; Suzuki M; Yamauchi A; Kato K; Kawashima N; Nemoto Y; Maruo T; Kawakami Y; Yamashita T
    Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129723. PubMed ID: 32861756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay Development and Screening for the Identification of Ganglioside GM3 Synthase Inhibitors.
    Yamanaka K; Takahashi Y; Azuma Y; Hantani Y
    Biochemistry; 2020 Mar; 59(12):1242-1251. PubMed ID: 32163271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialyltransferase Activity Assay for Ganglioside GM3 Synthase.
    Inamori KI; Nitta T; Shishido F; Watanabe S; Ohno I; Inokuchi JI
    Methods Mol Biol; 2023; 2613():101-110. PubMed ID: 36587074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural-specific alterations in glycosphingolipid biosynthesis and cell signaling associated with two human ganglioside GM3 synthase deficiency variants.
    Dookwah M; Wagner SK; Ishihara M; Yu SH; Ulrichs H; Kulik MJ; Zeltner N; Dalton S; Strauss KA; Aoki K; Steet R; Tiemeyer M
    Hum Mol Genet; 2023 Dec; 32(24):3323-3341. PubMed ID: 37676252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of ganglioside synthesis by GM3 synthase knockout in murine embryonic fibroblasts.
    Shevchuk NA; Hathout Y; Epifano O; Su Y; Liu Y; Sutherland M; Ladisch S
    Biochim Biophys Acta; 2007 Sep; 1771(9):1226-34. PubMed ID: 17604219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GM3 and diabetes.
    Inokuchi J
    Glycoconj J; 2014 Apr; 31(3):193-7. PubMed ID: 24399479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane microdomains and insulin resistance.
    Inokuchi J
    FEBS Lett; 2010 May; 584(9):1864-71. PubMed ID: 19822143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total loss of GM3 synthase activity by a normally processed enzyme in a novel variant and in all ST3GAL5 variants reported to cause a distinct congenital disorder of glycosylation.
    Indellicato R; Parini R; Domenighini R; Malagolini N; Iascone M; Gasperini S; Masera N; dall'Olio F; Trinchera M
    Glycobiology; 2019 Mar; 29(3):229-241. PubMed ID: 30576498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM3 synthase deficiency increases brain glucose metabolism in mice.
    Bharathi SS; Zhang BB; Paul E; Zhang Y; Schmidt AV; Fowler B; Wu Y; Tiemeyer M; Inamori KI; Inokuchi JI; Goetzman ES
    Mol Genet Metab; 2022 Dec; 137(4):342-348. PubMed ID: 36335793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of signal transduction by gangliosides in lipid rafts: focus on GM3-IR and GM1-TrkA interactions.
    Lunghi G; Fazzari M; Ciampa MG; Mauri L; Di Biase E; Chiricozzi E; Sonnino S
    FEBS Lett; 2022 Dec; 596(24):3124-3132. PubMed ID: 36331354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ganglioside biosynthesis as a novel therapeutic approach in insulin resistance.
    Inokuchi J
    Handb Exp Pharmacol; 2011; (203):165-78. PubMed ID: 21484572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.